INS and type 2 diabetes mellitus: However, a 2024 literature review of 22 studies11 concluded that a major driver of inertia for treatment intensification with insulin was fear of hypoglycaemia on the part of physicians, along with so‐called ‘psychological insulin resistance’ on the part of people with T2D related to their beliefs and perceptions of insulin and hypoglycaemia.12